- Home
- BFRI vs PAVM Comparison
BFRI vs PAVM Comparison
Compare BFRI & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRI | PAVM |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | 93 | 107 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 8.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BFRI | PAVM |
|---|---|---|
| Price | $0.90 | $9.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.75 | ★ $510.00 |
| AVG Volume (30 Days) | ★ 492.6K | 121.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.37 | N/A |
| Revenue Next Year | $10.96 | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $0.21 |
| 52 Week High | $1.18 | $28.44 |
Technical Indicators
Market Signals| Indicator | BFRI | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 52.26 | 56.03 |
| Support Level | $0.81 | $0.39 |
| Resistance Level | $0.91 | $12.50 |
| Average True Range (ATR) | 0.08 | 0.94 |
| MACD | 0.01 | -0.20 |
| Stochastic Oscillator | 73.91 | 59.84 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.